These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 8733131)
1. Expression of the von Hippel-Lindau disease tumour suppressor gene during human embryogenesis. Richards FM; Schofield PN; Fleming S; Maher ER Hum Mol Genet; 1996 May; 5(5):639-44. PubMed ID: 8733131 [TBL] [Abstract][Full Text] [Related]
2. Expression of the Von Hippel-Lindau tumor suppressor gene, VHL, in human fetal kidney and during mouse embryogenesis. Kessler PM; Vasavada SP; Rackley RR; Stackhouse T; Duh FM; Latif F; Lerman MI; Zbar B; Williams BR Mol Med; 1995 May; 1(4):457-66. PubMed ID: 8521303 [TBL] [Abstract][Full Text] [Related]
3. Phenotypic expression in von Hippel-Lindau disease: correlations with germline VHL gene mutations. Maher ER; Webster AR; Richards FM; Green JS; Crossey PA; Payne SJ; Moore AT J Med Genet; 1996 Apr; 33(4):328-32. PubMed ID: 8730290 [TBL] [Abstract][Full Text] [Related]
4. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease. Zatyka M; da Silva NF; Clifford SC; Morris MR; Wiesener MS; Eckardt KU; Houlston RS; Richards FM; Latif F; Maher ER Cancer Res; 2002 Jul; 62(13):3803-11. PubMed ID: 12097293 [TBL] [Abstract][Full Text] [Related]
5. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function. Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720 [TBL] [Abstract][Full Text] [Related]
6. Germline mutation profile of the VHL gene in von Hippel-Lindau disease and in sporadic hemangioblastoma. Olschwang S; Richard S; Boisson C; Giraud S; Laurent-Puig P; Resche F; Thomas G Hum Mutat; 1998; 12(6):424-30. PubMed ID: 9829912 [TBL] [Abstract][Full Text] [Related]
7. Reconsideration of biallelic inactivation of the VHL tumour suppressor gene in hemangioblastomas of the central nervous system. Gläsker S; Bender BU; Apel TW; van Velthoven V; Mulligan LM; Zentner J; Neumann HP J Neurol Neurosurg Psychiatry; 2001 May; 70(5):644-8. PubMed ID: 11309459 [TBL] [Abstract][Full Text] [Related]
8. Von Hippel-Lindau tumour suppressor gene. Localization of expression by in situ hybridization. Nagashima Y; Miyagi Y; Udagawa K; Taki A; Misugi K; Sakai N; Kondo K; Kaneko S; Yao M; Shuin T J Pathol; 1996 Nov; 180(3):271-4. PubMed ID: 8958804 [TBL] [Abstract][Full Text] [Related]
9. Germ-line mutations in the von Hippel-Lindau tumor-suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma. Whaley JM; Naglich J; Gelbert L; Hsia YE; Lamiell JM; Green JS; Collins D; Neumann HP; Laidlaw J; Li FP Am J Hum Genet; 1994 Dec; 55(6):1092-102. PubMed ID: 7977367 [TBL] [Abstract][Full Text] [Related]
11. Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene. Stolle C; Glenn G; Zbar B; Humphrey JS; Choyke P; Walther M; Pack S; Hurley K; Andrey C; Klausner R; Linehan WM Hum Mutat; 1998; 12(6):417-23. PubMed ID: 9829911 [TBL] [Abstract][Full Text] [Related]
12. Role of the von Hippel-Lindau tumor suppressor protein during neuronal differentiation. Kanno H; Saljooque F; Yamamoto I; Hattori S; Yao M; Shuin T; U HS Cancer Res; 2000 Jun; 60(11):2820-4. PubMed ID: 10850421 [TBL] [Abstract][Full Text] [Related]
13. Von Hippel-Lindau syndrome. A pleomorphic condition. Friedrich CA Cancer; 1999 Dec; 86(11 Suppl):2478-82. PubMed ID: 10630173 [TBL] [Abstract][Full Text] [Related]
14. Somatic mosaicism in von Hippel-Lindau Disease. Murgia A; Martella M; Vinanzi C; Polli R; Perilongo G; Opocher G Hum Mutat; 2000 Jan; 15(1):114. PubMed ID: 10612832 [TBL] [Abstract][Full Text] [Related]
15. Von Hippel-Lindau disease and sporadic renal cell carcinoma. Zbar B Cancer Surv; 1995; 25():219-32. PubMed ID: 8718521 [TBL] [Abstract][Full Text] [Related]
16. Multiple intracerebral haemangioblastomas in identical twins with von Hippel-Lindau disease--a clinical and molecular study. Sobottka SB; Frank S; Hampl M; Schackert HK; Schackert G Acta Neurochir (Wien); 1998; 140(3):281-5. PubMed ID: 9638266 [TBL] [Abstract][Full Text] [Related]
17. Renal cell carcinoma development in the rat independent of alterations at the VHL gene locus. Walker C; Ahn YT; Everitt J; Yuan X Mol Carcinog; 1996 Feb; 15(2):154-61. PubMed ID: 8599582 [TBL] [Abstract][Full Text] [Related]
18. Genetic and functional analysis of the von Hippel-Lindau (VHL) tumour suppressor gene promoter. Zatyka M; Morrissey C; Kuzmin I; Lerman MI; Latif F; Richards FM; Maher ER J Med Genet; 2002 Jul; 39(7):463-72. PubMed ID: 12114475 [TBL] [Abstract][Full Text] [Related]
19. Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C. Kibel A; Iliopoulos O; DeCaprio JA; Kaelin WG Science; 1995 Sep; 269(5229):1444-6. PubMed ID: 7660130 [TBL] [Abstract][Full Text] [Related]
20. The impact of molecular genetic analysis of the VHL gene in patients with haemangioblastomas of the central nervous system. Gläsker S; Bender BU; Apel TW; Natt E; van Velthoven V; Scheremet R; Zentner J; Neumann HP J Neurol Neurosurg Psychiatry; 1999 Dec; 67(6):758-62. PubMed ID: 10567493 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]